Correlation Between Mediantechn and Innate Pharma
Can any of the company-specific risk be diversified away by investing in both Mediantechn and Innate Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mediantechn and Innate Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mediantechn and Innate Pharma, you can compare the effects of market volatilities on Mediantechn and Innate Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mediantechn with a short position of Innate Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mediantechn and Innate Pharma.
Diversification Opportunities for Mediantechn and Innate Pharma
0.67 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Mediantechn and Innate is 0.67. Overlapping area represents the amount of risk that can be diversified away by holding Mediantechn and Innate Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Innate Pharma and Mediantechn is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mediantechn are associated (or correlated) with Innate Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Innate Pharma has no effect on the direction of Mediantechn i.e., Mediantechn and Innate Pharma go up and down completely randomly.
Pair Corralation between Mediantechn and Innate Pharma
Assuming the 90 days trading horizon Mediantechn is expected to under-perform the Innate Pharma. But the stock apears to be less risky and, when comparing its historical volatility, Mediantechn is 1.29 times less risky than Innate Pharma. The stock trades about -0.04 of its potential returns per unit of risk. The Innate Pharma is currently generating about 0.23 of returns per unit of risk over similar time horizon. If you would invest 150.00 in Innate Pharma on September 18, 2024 and sell it today you would earn a total of 55.00 from holding Innate Pharma or generate 36.67% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Mediantechn vs. Innate Pharma
Performance |
| Timeline |
| Mediantechn |
| Innate Pharma |
Mediantechn and Innate Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Mediantechn and Innate Pharma
The main advantage of trading using opposite Mediantechn and Innate Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mediantechn position performs unexpectedly, Innate Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Innate Pharma will offset losses from the drop in Innate Pharma's long position.The idea behind Mediantechn and Innate Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Complementary Tools
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |